Castleman M.
The Healing Herbs: The Ultimate Guide to the Curative Power of Nature's Medicines. Emmaus, Pa: Rodale Press; 1991:173 - 176.
Johnson ES, Kadam NP, Hylands DM, et al. Efficacy of feverfew as prophylactic treatment of migraine.
Br Med J (Clin Res Ed). 1985;291:569 - 573.
Bohlmann F, Zdero C. Sesquiterpene lactones and other constituents from
Tanacetum parthenium.
Phytochemistry. 1982;21:2543 - 2549.
Makheja AN, Bailey JM. The active principle in feverfew [letter].
Lancet. 1981;2:1054.
Makheja AN, Bailey JM. A platelet phospholipase inhibitor from the medicinal herb feverfew (
Tanacetum parthenium).
Prostaglandins Leukot Med. 1982;8:653 - 660.
Heptinstall S, White A, Williamson L, et al. Extracts from feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes.
Lancet. 1985;1:1071 - 1074.
Tyler VE.
Herbs of Choice: The Therapeutic Use of Phytomedicinals. New York, NY: Pharmaceutical Products Press; 1994:127.
De Weerdt CJ, Bootsma HPR, Hendriks H. Herbal medicines in migraine prevention. Randomized double-blind, placebo-controlled crossover trial of a feverfew preparation.
Phytomedicine. 1996;3:225 - 230.
Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind, placebo-controlled trial of feverfew in migraine prevention.
Lancet. 1988;2:189 - 192.
Palevitch D, Earon G, Carasso R. Feverfew (
Tanacetum parthenium) as a prophylactic treatment for migraine: a double-blind, placebo-controlled study.
Phytother Res. 1997;11:508 - 511.
De Weerdt CJ, Bootsma HPR, Hendriks H. Herbal medicines in migraine prevention. Randomized double-blind, placebo-controlled crossover trial of a feverfew preparation.
Phytomedicine. 1996;3:225 - 230.
Pfaffenrath V, Diener H, Fischer M, et al. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis-a double-blind, multicentre, randomized placebo-controlled dose-response study.
Cephalalgia.
2002;22:523-532.
Newall C, Anderson LA, Phillipson JD.
Herbal Medicines: A Guide for Health-Care Professionals. London, England: Pharmaceutical Press; 1996:120.
Murphy JJ, Heptinstall S, Mitchell JR. Randomised double-blind, placebo-controlled trial of feverfew in migraine prevention.
Lancet. 1988;2:189 - 192.
Johnson ES, Kadam NP, Hylands DM, et al. Efficacy of feverfew as prophylactic treatment of migraine.
Br Med J (Clin Res Ed). 1985;291:569 - 573.
Johnson ES, Kadam NP, Hylands DM, et al. Efficacy of feverfew as prophylactic treatment of migraine.
Br Med J (Clin Res Ed). 1985;291:569 - 573.
European Scientific Cooperative on Phytotherapy.
Tanaceti parthenii herba/folium (feverfew).
Exeter UK: ESCOP; 1996. Monographs on the Medicinal Uses of Plant Drugs, Fascicule 2
Collier HO, Butt NM, McDonald-Gibson WJ, et al. Extract of feverfew inhibits prostaglandin biosynthesis.
Lancet.
1980;2:922 - 923.
Sumner H, Salan U, Knight DW, et al. Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components.
Biochem Pharmacol.
1992;43:2313 - 2320.
Williams CA, Hoult JR, Harborne JB, et al. A biologically active lipophilic flavonol from
Tanacetum parthenium.Phytochemistry.
1995;38:267 - 270.
Pfaffenrath V, Diener H, Fischer M, et al. The efficacy and safety of Tanacetum parthenium (feverfew) in migraine prophylaxis-a double-blind, multicentre, randomized placebo-controlled dose-response study.
Cephalalgia.
2002;22:523-532.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.